NDC Package 55154-1425-8 Invokana

Canagliflozin Tablet, Film Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
55154-1425-8
Package Description:
2070 TABLET, FILM COATED in 1 BOTTLE
Product Code:
Proprietary Name:
Invokana
Non-Proprietary Name:
Canagliflozin
Substance Name:
Canagliflozin
Usage Information:
Canagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Canagliflozin is also used by people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Canagliflozin is also used by people with type 2 diabetes and kidney disease to lower the risk of dialysis, death from heart disease, and the need to go to the hospital for heart failure. Canagliflozin works by increasing the removal of sugar by your kidneys.
11-Digit NDC Billing Format:
55154142508
NDC to RxNorm Crosswalk:
  • RxCUI: 1373463 - canagliflozin 100 MG Oral Tablet
  • RxCUI: 1373463 - canagliflozin (as canagliflozin hemihydrate) 100 MG Oral Tablet
  • RxCUI: 1373469 - Invokana 100 MG Oral Tablet
  • RxCUI: 1373469 - canagliflozin 100 MG Oral Tablet [Invokana]
  • RxCUI: 1373471 - canagliflozin 300 MG Oral Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Cardinal Health 107, Llc
    Dosage Form:
    Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA204042
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    03-29-2013
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 55154-1425-8?

    The NDC Packaged Code 55154-1425-8 is assigned to a package of 2070 tablet, film coated in 1 bottle of Invokana, a human prescription drug labeled by Cardinal Health 107, Llc. The product's dosage form is tablet, film coated and is administered via oral form.

    Is NDC 55154-1425 included in the NDC Directory?

    Yes, Invokana with product code 55154-1425 is active and included in the NDC Directory. The product was first marketed by Cardinal Health 107, Llc on March 29, 2013 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 55154-1425-8?

    The 11-digit format is 55154142508. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-155154-1425-85-4-255154-1425-08